Fate Therapeutics FATE
NASDAQ FATE
$1.61 -0.16 (-9.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Fate Therapeutics (FATE) Other Investing Activities (as filed) (2013 - 2014)

Updated

Fate Therapeutics' Other Investing Activities was $122,000 in Q2 2025.

Analysis

Fate Therapeutics (FATE) Other Investing Activities (as filed) (2013 - 2014) Analysis & Trends

From Q3 2013 onward, Fate Therapeutics has reported Other Investing Activities for 6 quarters.

  • The Q2 2025 figure marks the highest quarterly Other Investing Activities since Q2 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other investing (as filed) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 86.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 352.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 946.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -54.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -3.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -60.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -62.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 14.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 79.00 Mn
10 Fate Therapeutics 215.18 Mn 76.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -122,000.00
Sep 30, 2013 -122,000.00
API Access

Fate Therapeutics Other Investing Activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-investing-activities&ticker=FATE&period=max&api_key=YOUR_API_KEY